Bingham Osborn & Scarborough’s Albemarle ALB Stock Holding History

Bingham Osborn & Scarborough’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,921	Closed	-$350K	–	134
2020 Q3	$350K	Hold	3,921	–	–	0.03%	118
2020 Q2	$303K	Sell	3,921 -16	-0.4%	-$1.09K	0.02%	118
2020 Q1	$222K	Buy	3,937 +32	+0.8%	+$2.45K	0.02%	133
2019 Q4	$285K	Sell	3,905 -42	-1%	-$2.8K	0.02%	128
2019 Q3	$274K	Buy	3,947 +2	+0.1%	+$136	0.02%	119
2019 Q2	$278K	Buy	3,945 +54	+1%	+$3.99K	0.02%	116
2019 Q1	$319K	Sell	3,891 -112	-3%	-$9.16K	0.03%	109
2018 Q4	$309K	Hold	4,003	–	–	0.03%	105
2018 Q3	$399K	Hold	4,003	–	–	0.04%	96
2018 Q2	$378K	Buy	4,003 +112	+3%	+$10.8K	0.04%	97
2018 Q1	$361K	Sell	3,891 -13	-0.3%	-$1.43K	0.03%	97
2017 Q4	$499K	Buy	+3,904	New	+$530K	0.05%	75

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Bingham Osborn & Scarborough's ALB Position: Q4 2020 in Review

Bingham Osborn & Scarborough sold out of Albemarle (ALB) in Q4 2020, closing a stake of 3,921 shares — an estimated $350K sold.

Bingham Osborn & Scarborough first reported a position in ALB in Q4 2017 and held it in 12 quarters. The position peaked at $499K in Q4 2017. 674 funds tracked by Wall St. Rank hold ALB as of Q4 2020.

Bingham Osborn & Scarborough reported no remaining Albemarle position as of Q4 2020 after selling out during the quarter.
Bingham Osborn & Scarborough sold 3,921 Albemarle shares in Q4 2020, an estimated $350K.
Bingham Osborn & Scarborough first reported a position in Albemarle in Q4 2017 and held it in 12 quarters.
Bingham Osborn & Scarborough's Albemarle position peaked at $499K in Q4 2017.
674 funds tracked by Wall St. Rank held Albemarle as of Q4 2020.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2020, filed 11 Feb 2021.